Published in Neurodegener Dis on February 18, 2010
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. J Mol Biol (2011) 1.42
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem (2010) 1.28
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem (2011) 1.22
A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation. J Biol Chem (2013) 0.97
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. PLoS One (2011) 0.96
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways. J Neurochem (2014) 0.95
Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS One (2011) 0.91
Models for LRRK2-Linked Parkinsonism. Parkinsons Dis (2011) 0.91
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? Mol Neurodegener (2011) 0.85
Interaction of LRRK2 with kinase and GTPase signaling cascades. Front Mol Neurosci (2014) 0.82
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Hum Mol Genet (2014) 0.82
ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. Protein Cell (2013) 0.77
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. Mol Neurodegener (2017) 0.75
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway. Mol Neurodegener (2017) 0.75
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron (2004) 14.35
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron (2004) 13.99
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A (2005) 6.98
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis (2006) 5.96
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet (2007) 4.99
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med (2006) 3.90
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J (2007) 3.89
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem (2008) 3.86
Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol (2001) 3.84
Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol (2006) 3.72
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J (2008) 3.51
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci U S A (2005) 3.00
RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ (2007) 2.96
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med (2006) 2.93
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro (2009) 2.85
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J Biol Chem (2008) 2.77
The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci (2005) 2.56
The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun (2007) 2.42
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A (2008) 2.36
alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci (1999) 2.25
Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology (2006) 1.81
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J Biol Chem (2009) 1.79
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J Neurochem (2009) 1.71
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J Neurochem (2007) 1.70
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci (2009) 1.64
Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J (2008) 1.62
The JIP family of MAPK scaffold proteins. Biochem Soc Trans (2006) 1.62
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease. Biochim Biophys Acta (2008) 1.55
Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol (2005) 1.53
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? Trends Mol Med (2006) 1.44
Mixed-lineage kinases: a target for the prevention of neurodegeneration. Annu Rev Pharmacol Toxicol (2004) 1.43
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci (2009) 1.42
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. J Neurochem (2009) 1.42
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem (2010) 1.28
Genes associated with Parkinson syndrome. J Neurol (2008) 1.21
alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem (2002) 1.13
Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. J Biol Chem (2003) 0.94
Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein. Mol Neurodegener (2008) 0.84
ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet (1998) 3.66
alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci (1999) 2.25
Screening and management of renal disease in human immunodeficiency virus-infected patients in Australia. Intern Med J (2013) 2.01
Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J (1984) 1.98
Technical basis for EPA's proposed regulation on the cleanup of sites contaminated with radioactivity. Health Phys (1996) 1.92
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
Bedside emergency department ultrasonography plus radiography of the kidneys, ureters, and bladder vs intravenous pyelography in the evaluation of suspected ureteral colic. Acad Emerg Med (1998) 1.74
Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc Natl Acad Sci U S A (1998) 1.71
Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J Cell Biol (1998) 1.69
Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clin Pharmacol Ther (1991) 1.62
Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J (1986) 1.62
Paramedic vs private transportation of trauma patients. Effect on outcome. Arch Surg (1996) 1.61
The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clin Endocrinol (Oxf) (2009) 1.57
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals. Clin Infect Dis (2014) 1.51
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci (2000) 1.51
Prosthetic replacement of the distal femur for primary bone tumours. J Bone Joint Surg Br (1991) 1.49
Validity of the US Behavioral Risk Factor Surveillance System's health related quality of life survey tool in a group of older Canadians. Chronic Dis Can (2001) 1.47
A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV. J Biol Chem (1990) 1.47
The six-minute walk test in healthy children: reliability and validity. Eur Respir J (2005) 1.44
The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology (1997) 1.43
Ultrasound training for emergency physicians--a prospective study. Acad Emerg Med (2000) 1.42
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology (2003) 1.42
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1986) 1.41
Efficacy of multidisciplinary approach in treatment of constipation: a pilot study. Hong Kong Med J (2006) 1.37
Waist circumference and body mass index in Chinese children: cutoff values for predicting cardiovascular risk factors. Int J Obes (Lond) (2006) 1.37
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. Ann Oncol (2012) 1.34
A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta. J Biol Chem (1989) 1.34
Identification of Enterococcus species and phenotypically similar Lactococcus and Vagococcus species by reverse checkerboard hybridization to chaperonin 60 gene sequences. J Clin Microbiol (2000) 1.34
Long-term retrograde amnesia...the crucial role of the hippocampus. Neuropsychologia (2001) 1.31
Longitudinal stability of CSF tau levels in Alzheimer patients. Biol Psychiatry (1999) 1.30
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J Biol Chem (1989) 1.27
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
The effects of obesity on pulmonary function. Arch Dis Child (2003) 1.26
Direct association of presenilin-1 with beta-catenin. FEBS Lett (1998) 1.26
Collagen composition of normal and myxomatous human mitral heart valves. Biochem J (1984) 1.25
Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA. J Biol Chem (1988) 1.21
Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum (2000) 1.19
Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J Biol Chem (1996) 1.17
SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res (2003) 1.17
Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment. Neurology (2002) 1.17
Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. Exp Neurol (2005) 1.14
In vitro chondrogenic differentiation of human mesenchymal stem cells in collagen microspheres: influence of cell seeding density and collagen concentration. Biomaterials (2008) 1.12
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. Br J Cancer (2001) 1.10
Analysis of the heterogeneity of human collagens by two-dimensional polyacrylamide-gel electrophoresis. Biochem J (1981) 1.09
The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology (1998) 1.08
Phenotypic and population differences in the association between CILP and lumbar disc disease. J Med Genet (2007) 1.07
Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res (1991) 1.06
Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging (2007) 1.06
Identification of the gene for fly non-muscle myosin heavy chain: Drosophila myosin heavy chains are encoded by a gene family. EMBO J (1989) 1.05
High performance DNA sequencing, and the detection of mutations and polymorphisms, on the Clipper sequencer. Electrophoresis (1999) 1.02
RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene (2006) 1.01
Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways. Proc Natl Acad Sci U S A (1990) 0.99
A rat serum glycoprotein whose synthesis rate increases greatly during inflammation. J Biol Chem (1979) 0.98
Rapid fractionation of collagen chains and peptides by high-performance liquid chromatography. Anal Biochem (1986) 0.98
Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr (1991) 0.95
Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form. Matrix Biol (2001) 0.95
The prevalence and effect of alcohol and drug abuse on cohort-matched critically injured patients. Am Surg (1998) 0.95
Hemostatic laparoscopic partial nephrectomy: initial experience with the radiofrequency coagulation-assisted technique. Urology (2001) 0.94
Comprehensive analysis of collagen metabolism in vitro using [4(3H)]/[14C]proline dual-labeling and polyacrylamide gel electrophoresis. Anal Biochem (1988) 0.94
A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Am J Pathol (2001) 0.93
Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res (1992) 0.92
Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion. J Biol Chem (2001) 0.92
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study. J Eur Acad Dermatol Venereol (2012) 0.91
Surface mechanical properties, corrosion resistance, and cytocompatibility of nitrogen plasma-implanted nickel-titanium alloys: a comparative study with commonly used medical grade materials. J Biomed Mater Res A (2007) 0.91
Quantitation of type I and III collagens using electrophoresis of alpha chains and cyanogen bromide peptides. Anal Biochem (1984) 0.91
Evaluation and management of men whose radical prostatectomies failed: results of an international survey. Urology (1998) 0.90
Overuse injuries of the olecranon in young gymnasts. J Bone Joint Surg Br (1992) 0.90
Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens (2011) 0.89
Prognostic significance of total disease length in esophageal cancer. Surg Endosc (2012) 0.89
Stereospecific syntheses of iridomyrmecin and related iridolactones. Tetrahedron (1965) 0.89
Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord (1999) 0.89
Socio-economic deprivation and excess winter mortality and emergency hospital admissions in the South Yorkshire Coalfields Health Action Zone, UK. Public Health (2004) 0.87
A cross sectional study to examine the association between dietary patterns and cognitive impairment in older Chinese people in Hong Kong. J Nutr Health Aging (2013) 0.87
Methanolysis of the intervertebral disc. Clin Chem (1967) 0.87
Lipid-lowering treatment is related to decreased risk of dementia: a population-based study (FINRISK). Neurodegener Dis (2010) 0.87
Improved outcomes following the introduction of surfactant to an Australian neonatal unit. J Paediatr Child Health (1996) 0.87
VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells. Breast Cancer Res Treat (2001) 0.87
Human olfactory neuroepithelial cells: tyrosine phosphorylation and process extension are increased by the combination of IL-1beta, IL-6, NGF, and bFGF. Exp Neurol (1996) 0.87
Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of alpha 1 (I)-chain glycine-to-arginine substitutions. Biochem J (1989) 0.86
The effect on the bonding strength of orthodontic brackets of fluoride application after etching. Am J Orthod Dentofacial Orthop (1989) 0.86
Duplex ultrasound evaluation for dialysis access selection and maintenance: a practical guide. J Vasc Access (2008) 0.86
A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer. Br J Cancer (2003) 0.86
Osteogenic behavior of alginate encapsulated bone marrow stromal cells: an in vitro study. J Mater Sci Mater Med (2006) 0.86
Mesenchymal stem cell-based repair of articular cartilage with polyglycolic acid-hydroxyapatite biphasic scaffold. Int J Artif Organs (2008) 0.86
Combined anterior interbody fusion and posterior pedicle screw fixation in patients with degenerative lumbar disc disease. Int Orthop (2004) 0.86
A clinical comparison of resin composite inlay and onlay posterior restorations and cast-gold restorations at 7 years. Quintessence Int (1999) 0.86
Current followup strategies after radical prostatectomy: a survey of American Urological Association urologists. J Urol (1999) 0.85
Processing and purity assessment of standards for the analysis of type-B trichothecene mycotoxins. Anal Bioanal Chem (2005) 0.85
What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res (2010) 0.85
In vitro evaluation of alginate encapsulated adipose-tissue stromal cells for use as injectable bone graft substitute. Biochem Biophys Res Commun (2006) 0.85
Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer. Br J Cancer (2011) 0.85
Minilaparotomy radical retropubic prostatectomy: technique and results. J Urol (1998) 0.84
Combined anterior and posterior stabilisation for treating an unstable cervical spine fracture in a patient with long standing ankylosing spondylitis. Injury (2004) 0.84
CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity. J Immunol (2000) 0.83
Hydration dynamics of human fingernails: an ellipsometric study. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.83